Good day, and welcome to the Advance 6-3Q25 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star than 1 on your telephone keypad, and to withdraw your question, please press star than 2. Please note today's event is being recorded. I would now like to turn the conference over to Adam Kressel, Vice President, Investor Relations, and Treasurer. Please go ahead.

Thank you, Rocco. Good morning, and welcome to Advance 6's third quarter 2025 earnings conference call. With me here today are President and CEO Aaron Cain and Interim CFO Chris Graham. This call and webcast, including any non-GAAP reconciliations, are available on our website at investors.advance6.com. Note that elements of this presentation contain forward-looking statements that are based on our best view of the world and of our business as we see it today. Those elements can change, and the actual results could differ materially from those projected, and we ask that you consider them in that light. We refer you to the forward-looking statements included in our press release and earnings presentation. In addition, we identify the principal risks and uncertainties that affect our performance in our SEC filings, including our annual report on Form 10-K as further updated in subsequent filings with the SEC. This morning, we will review our financial results for the third quarter of 2025 and share our outlook for our key product lines and end markets. Finally, we'll leave time for your questions at the end. So with that, I'll turn the call over to Advance 6's President and CEO, Erin Kane.

Thanks, Adam, and good morning, everyone. We appreciate you joining us here today for our quarterly call. As you saw in our press release, Advances continued to navigate challenging industry dynamics in the third quarter with a focus on optimizing operational and commercial performance. Our team executed with agility and discipline as we seasonally entered a new fertilizer year in plant nutrients with a strong fall-fill program amid higher raw material input costs, while continuing to realize the ongoing benefits from our sustained growth program. Given the protracted downturn in nylon solutions and demand softness in chemical intermediates, we're making the strategic choice to moderate production rates to manage inventory levels with a keen focus on free cash flow. Utilization across our integrated value chain was down roughly 4 percentage points sequentially from the second quarter to the third. Operationally, we experienced a site-wide electrical outage at our Chesterfield Nylon plant in mid-September. While there was minimal impact to 3Q results, we did have an isolated fire upon restart that impacted one polymerization line of the plant and was fully contained. There were no injuries or environmental impacts, and the majority of our plant operations continue as normal. So while we were already tactically opting to reduce production levels, this incident is expected to impact 4Q EBITDA by $7 to $9 million, primarily related to the negative impact of unabsorbed fixed costs. On a positive note, our fourth quarter planned plant turnaround, centered around our sulfuric acid and oleum plant at Hopewell, was completed successfully at the low end of our target range. While our domestic nylon solution margins over benzene once again expanded year-over-year, we are seemingly operating in a lower-for-longer macro environment. In times of uncertainty, we're focused on delivering on controllable levers. This includes continued optimization of production output and sales volume mix while driving productivity to support through-cycle profitability. Taking a disciplined approach to cash management is critical. reflected in our prioritization of base capital investment and anticipated tailwinds in 2026 from 45Q carbon tax credits and recent tax legislation. 2025 CapEx is now expected to be $120 to $125 million, reflecting $30 million full-year cash conservation through refined risk-based prioritization and execution. Our select and targeted investments for growth are continuing to progress. The Sustained Growth Program, which unlocks 200,000 tons of granular ammonium sulfate, has been favorably tracking roughly 15% below its capital budget, with the final two projects remaining to be completed over the next year. In addition, our planned investment to upgrade our enterprise resource planning system went live in the third quarter, which will help streamline key processes across the organization while enhancing management tools and data analytics. Finally, we added two new members to our Board of Directors this past quarter, Dana O'Brien and Daryl Roberts. Their deep industry and professional backgrounds and proven expertise in global manufacturing will be invaluable to our Board's role in ensuring strong corporate governance practices and supporting advancement of our strategic growth priorities. With that, I'll turn it over to Chris to discuss the financials.

Thanks, Aaron. I'm now on slide four to discuss our results for the quarter. Sales of $374 million in a quarter decreased approximately 6% versus the prior year. Sales volume was approximately half of that change, driven primarily by softer demand in both chemical intermediates and nylon end markets. Raw material pass-through pricing was down 5% following a cost decrease in benzene, which is a major input to cumene, our largest raw material and key feedstock to our products. Market-based pricing was favorable by approximately 2%, driven by continued strength in plant nutrients, reflecting favorable North American ammonium sulfate supply and demand conditions. Adjusted EBITDA was $25 million, down $28 million from last year, while adjusted EBITDA margin was 6.6%. The decline in earnings versus last year was primarily driven by a reduction in acetone price raw spreads, as we anticipated. The impact of lower nylon and chemical immediate sales and production volume and higher utility costs as a result of increasing natural gas prices. On a sequential basis, compared to the second quarter, we saw a nearly $20 million earnings decline due to typical ammonium sulfate seasonality with the start of the new fertilizer year. In addition, our results reflect the impact of moderated production rates amid softer demand for nylon solutions and chemical immediates. Now let's turn to slide five.

Here we are illustrating our quarterly sales contributions by product line, as well as price and volume breakdown, both year-over-year and sequentially. We believe this double-click into the underlying dynamics of our financials provides insight into our commercial sales and performance. Plant nutrients continues to positively stand out. While we navigated typical seasonal pricing considerations, our continued strong performance in Q3, including the higher year-over-year pricing of our FALFIL program and favorable sales mix supported by our sustained growth program, are further proof points to the resiliency of software nutrition demand. Brands. Broader nylon markets continue to face pressure here in the U.S. and abroad. However, domestic market-based pricing across nylon solutions is holding steady, while raw materials pass-through pricing saw declines on lower benzene input prices. And lastly, acetone pricing has moderated, as expected, from the multi-year highs witnessed in 2024. Let's turn to slide six. Our end market exposure remains a strategic advantage. It provides a source of diversification, which helps insulate the company from significant variability in any one industry, as demonstrated by our results in various environments. We've highlighted our exposure in descending order with agriculture and fertilizer at the top. This is an area that continues to grow. We estimate sovereign nutrition demand growing 3% to 4% per year on average, and where we are leveraging our expertise as leaders in this space. There continues to be robust acceptance of the sulfur value proposition amid underlying increases in global nitrogen pricing, primarily driven by supply-side impacts. Given current corn futures, this is a positive reinforcement that the value chain believes in sulfur to improve economics for the same acreage. We believe stock-to-use ratios globally continue to support fertilizer demand over the long term. Moving to building construction, dynamics here remain largely unchanged. Across this end application, we have direct and indirect exposure across nylon and intermediates through flooring, oriented strand board, and paints and coatings, to name just a few. Our view is latent demand will build and begin to recover through 2026, assuming moderating interest rates going forward. Plastics does remain challenged, reflecting broader macro softness. We had previously communicated that the auto sector was a watchout, including impacts of terrorist uncertainty and trade policy. We've continued to see a drawdown in auto inventories, as well as weakness across consumer durables and other industrial applications. Solvents likewise have been mixed. We've seen moderated growth into construction, pharmaceutical, and electronics industries. In the semiconductor space, our NAIDON sales demand was down year-over-year in the third quarter, but is anticipated to improve sequentially into 4Q and 2026. And lastly, we continue to monitor and track trends in food packaging, where beef is the largest category. Nylon 6 is preferred here due to its excellent barrier properties and its puncture resistance. Our inflationary pressure and tariffs are impacting demand in this space, notwithstanding the relative resilience we are seeing in packaging. Let's move to slide 7.

Cash flow generation remains a critical focus area for us. We believe it's important to view our business performance on a trailing 12-month basis given the linearity considerations, primarily driven by the timing of the fertilizer season. Trailing 12-month free cash flow through Q3 2025 is approximately break-even, and we continue to target positive free cash flow for the full year of 2025. There are a number of levers that we're focused on to bolster sustained and improve cash flow generation moving forward, including working capital initiatives, risk-based prioritization of capital investments, cost productivity, and tax optimization. Our balance sheet is positioned to provide optionality and the ability to weather the challenging macro environment. We expect strong free cash flow in the fourth quarter supported by working capital tailwinds, including the ammonium sulfate pre-buy cash advances. As Aaron mentioned earlier, we're able to capture a roughly $30 million reduction to our full-year 2025 capital plan. We expect CapEx for 2026 to be in the range of $125 million to $135 million. We're also actively managing our cash tax rate, which we anticipate being below 10% over the next few years, supported by the continued progress on the 45Q carbon capture tax credits and 100% bonus depreciation. Now let's turn to slide eight to wrap up before moving to Q&A.

Our strategic initiatives, unique combination of assets and business model, are core to our durable competitive advantage and long-term positioning. Our global low-cost position in vertically integrated caprolactam production serves us well. In addition, ammonia and sulfuric acid platform integration, coupled with a leading granular crystallization technology position, underpins our sustained ammonium sulfate growth and how we win in plant nutrients. These capabilities, combined with our acid utilization agility and product mix, position us to navigate cycles and capitalize on emerging opportunities. 2025 has been a dynamic year, but we remain well-positioned as an American manufacturer of essential chemistries. We have been operating with structural tariffs in place globally across our value chains for quite some time, so we are adept at navigating an environment like this. We are largely insulated from first-order impacts, reciprocal tariffs, with nearly 90% of our sales in the U.S. and our key product lines in a net import industry position. Our U.S. footprint has allowed us to optimize our tax position with a meaningful impact on cash flow going forward. Recently, we've seen a number of industry actions with announced European capacity rationalization in phenol and acetone, as well as caprolactam and ammonium sulfate. We believe we're reaching an inflection point in several markets, and as we've discussed today, we're positioning ourselves to win long term. With that, Adam, let's move to Q&A.

Thanks, Erin. And Rocco, can you please open the line for questions?

Of course. And as a reminder, if you'd like to ask a question, please press star than 1. If your question has already been addressed and you'd like to remove yourself from Q, please press star than 2. And our first question today comes from David Silver at Freedom Capital Markets. Please go ahead. Hello, Mr. Silver. Do you have any questions, sir? Is your line on mute, perhaps?

Yes, it was. I apologize. Thank you for that. I always like to build up the suspense there.

Good morning, David.

Good morning. And I apologize. Let me just get a tiny bit organized here. Sorry. Okay. So I did have, you know, a number of questions. I think first, I was hoping maybe you could provide a little additional color on the chemical intermediates, you know, market and pricing environment. So, you know, were the revenue declines and the margin pressures, was that primarily acetone or did the, you know, weakness extend to, you know, other key products or in-market? So maybe just a little more color on the fall-off in chemical intermediates results this quarter. Yeah.

Certainly, and we recognize that we provided some new, you know, formats here today, and we did go ahead and include the specific line of business industry spreads and KPI updates in the appendices for reference. But, yes, on the acetone side, you know, as you well know, David, you know, represents roughly 50% of, you know, our sales in chemical intermediates. And, you know, we would characterize, you know, Q3 as, you know, really more in line with our expectations, right? As we headed into the year, we've been saying that we did expect phenol demand overall to remain subdued, right? That would keep acetone supply and demand, you know, balanced, but that we were expecting that we would come off the highs of 2024 and certainly probably moderate back to cycle averages. And that's where we continue to see the market play out. You know, our portfolio is well-balanced between small, medium, and large buyer. That allows us, you know, quite a bit of flexibility to go where the value is in the market. And while the moves were significant kind of year-over-year, right, they are sort of moderating as we think about the adjustments, you know, to those cycle averages sequentially. But when you look across the rest of the portfolio, as you say, you know, we hear in, you know, a number of other end markets, whether it's electronics, paints and coatings, adhesives, you know, you kind of think about ag chemicals, the full space, you know, in general, we would say that there's, you know, continued, you know, views of softness. I think this is thematic, what you're seeing across the entire chemical sector, not necessarily anything unique to us. You know, we did call out the semiconductor space and NATO on demand. We're seeing signs that that's picking back up in Q4 with some, you know, site of improvement into 2026. So I would like to say that there's, you know, some opportunities in different places. We continue to stay focused, you know, in the right areas with favorable long-term trends, and that's what we're seeing there on intermediates. Hopefully that helps.

Okay, great. Thank you. I should have reviewed the appendix page. No, but. A lot of details is there. I would like to talk about the ammonium sulfate results this quarter. So, you know, the revenue number is quite striking. I believe that's your highest third quarter revenue total ever for that segment. And, you know, the summer quarter is typically, I guess, when you typically sell a little bit more of the standard product and into international markets. But, you know, maybe just looking at the third quarter results, I mean, was there a disproportionate amount of products sold into the U.S. market, or was there maybe some advanced purchasing? I mean, just maybe just a little more color on the strength in ammonium sulfate.

Yeah, so, you know, as you point out, right, prior to, you know, the sustain program, that would have been, you know, the trend we would have expected sort of Q2 into Q3. For us now, right, the additional granular volume that we are producing is coupled with a good fall, you know, pickup. We did have less standard to sell across the board, right? So that mixed differential is not as, you know, perhaps I would say geographical mixed consideration is not as great as it used to be. So, you know, certainly, you know, 3Q year-over-year granular volume was, you know, up 20%, right? And so, you know, again, that is really at the heart of, you know, the intent behind, you know, sustain. And obviously, with a year-over-year, prices for fill-up, you know, led to that revenue generation you saw.

Okay, great. Next question would be probably about raw material cost trends. So, you have cited some of the data, you know, again, in the appendix slides. but you know sulfur as you noted continues to track up upwards and natural gas has recently kind of shot up a bit maybe on anticipated winter demand here should we just assume that you are a spot market purchaser you know for the fourth quarter or would this would there be the case where maybe you were able to do some hedging or other pre-buying kind of ahead of the quarter. So maybe just a sense of how we should look at the spot market or the recent changes in some of your raw materials and the flow through to your fourth quarter results.

Yeah, that's a great question. I would say generally we typically don't, you know, execute hedges on a regular basis. Sulfur is, you know, probably not as widely traded, and so the hedging process there would command a premium. But I think for natural gas, generally we've elected to not enter a hedging strategy. What we've seen from gas, obviously from a year-over-year perspective, that the price has gone up from, let's say, an average of $2.30 a decatherm to $3.40 here this year. So obviously super sensitive to that, watching for that. Most of these two molecules do end up in ammonium sulfate. And while ammonium sulfate is generally based on value pricing, Input cost does have a tendency to put pressure on the least marginal producer, so it does have some indirect effect. I would say as well, particularly on the natural gas side with our formula pricing, that there is natural gas components there. And so even though we don't, let's say, execute a financial or a synthetic hedge, we do have some coverage in our formula-based pricing in the nylon business as well. So, hopefully, that gives you sort of a bit of color there, David, and kind of how we think about and react to some of these changes.

Okay, great. Maybe another one for Chris, but I was looking or hoping to get a bit of an update on the Section 45Q carbon capture credits that you've applied for and you may apply for in the future. So maybe just your sense of the timing for capturing, I guess, the first $20 million of credits that you've filed for, I guess, in the first half of the year. And then maybe is there an early read on what you may be filing for next year?

Yeah, no, that's a great question. Obviously, 45Q is a significant value driver for us. And just as a reminder, you know, we perfected the 2018 claim last year and 2019 and 2020 this year. Based on, you know, those perfected claims, we filed amended returns. Those amended returns, as you can imagine, trigger an audit process that we have to work through. We're confident based on all the upfront work that we've done both with the Department of Energy and with the IRS that will be successful through that audit process. What I would say is due to the government shutdown, I think the timing of when we would expect to receive the credits that we have applied for looks like that that's going to be shifting to 2026. I would point out that our early comment on positive free cash flow for the 2025 year does take that shift into account. So we still believe we're going to be positive free cash flow in 2025. We do expect a cumulative benefit, once again, of $120 million across the life of the program. Just as an update, we filed the 2021 lifecycle assessment, and that needs to be reviewed and approved by the Department of Energy and the IRS. Under normal circumstances, that would take probably three to four months. So we're hoping that, you know, in short order, once things sort of get back to a bit normal, that it wouldn't be too long until we get approval for that. So we're going to continue to obviously provide you updates as we move forward and move along, but we continue to push the opportunity there and the progress as well.

Okay, thanks. And I think this one's also for Chris. But, you know, I have seen how your carbon capture credits flow through your income statement. Can you just remind me regarding bonus depreciation? Is that something that will impact, you know, your gap or gap and non-gap results? Or is that something that strictly shows up on your tax filings? Just, you know, the impact of bonus depreciation is on how I should think about my estimates for next year. Does that impact them, or is the impact solely going to be reflected on, you know, your tax-based filings?

Yeah, no, great question. Just as a reminder, the 100% bonus depreciation really affects our cash tax rate. So if you think about our effective tax rate, it looks at and tries to book the expected, I call it, tax consequences of what our U.S. GAAP financial statements are. So I would expect the changes in the One Big Beautiful Bill Act won't have a significant impact on the effective tax rate, but it does have a very significant impact on our cash tax rate. And to just give you a little color, the biggest benefit on bonus depreciation is on acquired and placed-in-service assets after January 19th of this year. So the dollar benefit of projects that qualify for both of those is $2 million for the calendar year 25. As we move forward to 2026, the benefit is going to grow as more of the projects qualify for those criteria. And we expect that number to be sort of mid in the high single digits from a cash tax basis. And we would expect 27 to be even larger than that. So hopefully that gives you a sense there of how it will get expressed in sort of the order of magnitude as we move forward.

Okay. No, very, very helpful. I did get my CPA, but it was a long time ago. And thank you for walking me through that elapsed CPA. I know. I admit it. Yeah. Yeah. Yeah, so this one, you know, has to do with slide seven, and in particular, the next to the last bullet point where you talk about inventory management and then you say cost reduction initiatives for 2026. And I think it was touched on briefly in the prepared remarks, but just wondering if you could maybe talk about some of the buckets that go into that category of cost reduction initiatives for 2026. Thank you.

Sure. Sure. I mean, as you would expect, you know, our normal course focus on productivity includes things like, you know, optimizing yield, certainly inflationary energy environments, you know, energy utilization programs like this. Here specifically, you know, David, we're programmatically, you know, setting up to really address non-manpower fixed costs. You may see this, you know, across other companies when they announce these types of programs. You know, we believe that there is a meaningful opportunity for us to, I would say, target that programmatically. And that's what we're really pointing to here. So, you know, we would be in a position as we continue to set ourselves up for that. You know, it's likely a two-year type of a program, but in February, you know, we'd be happy to come back and, you know, certainly clarify and quantify, you know, what we expect to be our 2026 targets and sort of what our full run rate, you know, opportunity set would be for that program.

Okay. All right. Very good. And let me just ask, but am I – if I'm the only one here, I just have one or two kind of additional questions. Would that be okay or – Is there some – if not, I can get back in the queue.

Sure, David.

Okay. Earlier this quarter, you know, you did put out a press release regarding the, I guess, settlement over the – your intellectual property for, I guess, easy blocks. And, you know, I read the release, you know, with interest. I don't have it right in front of me. But I believe, you know, it was a settlement that your company considered, you know, satisfactory. And I was just wondering if qualitatively you might be able to discuss, you know, the nature of the settlement. In other words, are they going to be a new customer for you longer term or was there a monetary settlement? Just, you know, what was the nature of the settlement that in that, you know, intellectual property dispute that you considered, you know, to your satisfaction?

This is, you know, I think a win for us, obviously, when, you know, you spend the time, talent, and treasure, you know, to put good IP in place, you want to protect it. And, you know, so we have been certainly defending, you know, that opportunity set for ourselves. And so we certainly were, you know, pleased that we were able to agree and sort of resolve the differences of opinion there with, you know, the various parties. And, yes, with all agreements, you know, there is, you know, some monetary settlement. You have an agreement relative to the patent use and upholding, you know, licensing from that regard. But I think importantly here, it allows us to set up the right customer and distribution base that, you know, is living by, you know, the rightful upholding of the IP and allowing us to make sure that, you know, sort of importers that are coming from other regions of the world that are violating SOT-IP, you know, can be held at bay. So we do believe that ultimately this sets us up for, you know, increased sales, you know, as a result.

Okay, great. That's going to be it from me. I appreciate all the color.

Thanks, David. Thank you. And that does conclude our question and answer session. I'd like to turn the conference back over to Erin Cain for closing remarks.

Thank you all again for your time and interest this morning. Advancix is a resilient company, and we are positioning ourselves to win long term. We're navigating a challenging market environment with discipline and agility while continuing to make risk-adjusted investment decisions to support through-cycle profitability and sustainable performance. We're not just reacting to market conditions. We're shaping our future with a clear focus on value creation. And we're doing it with an integrated business model, durable competitive advantage, and a healthy balance sheet. With that, we look forward to speaking with you again next quarter. Stay safe and be well.

Thank you. That does conclude our conference call. We thank you all for attending today's presentation. You may now disconnect your lines and have a wonderful weekend.